JAMA: the journal of the American Medical Association 302, 412 (2009)
Macrophage inactivation by small molecule wedelolactone via targeting sEH for the treatment of LPS-induced acute lung injury
Ingredients Polybutene, Diisostearyl Malate, Hydrogenated Polyisobutene, Hydrogenated Poly(C6-14 Olefin), Trimethylolpropane Triisostearate, Phytosteryl/Isostearyl/Cetyl/Stearyl/Behenyl Dimer Dilinoleate, Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine, Octocrylene, Polyglyceryl-2 Triisostearate, Microcrystalline Wax, Ceresin, Diethylamino Hydroxybenzoyl Hexyl Benzoate, Ethylene/Propylene/Styrene Copolymer, Petrolatum, Ethylhexyl Palmitate, Butyrospermum Parkii (Shea) Butter, Parfum, Bisabolol, Tribehenin, BHT, Butylene/Ethylene/Styrene Copolymer, Sorbitan Isostearate, Palmitoyl Tripeptide-1, Lysine Carboxymethyl Cysteinate, Aqua, Glutathione, Pentylene Glycol, Sodium Acetylated Hyaluronate, Sodium Hyaluronate, Sodium Hyaluronate Crosspolymer, Hydrolyzed Sodium Hyaluronate, Ethylhexylglycerin, Benzyl Benzoate, Vanillin, CI 77891, CI 77492, CI 77491, CI 19140, CI 15850, CI 42090.
Methanogens in humans: potentially beneficial or harmful for health
